Clinicopathological characteristics of familial SLE patients with lupus nephritis

Lupus

Volumn 18, Issue 3, 2009, Pages 243-248

  Wang, Z ^a   Tang, Zheng ^a   Zhang, H T ^a   Hu, W X ^a   Liu, Z H ^a   Li, L S ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Familial; Histological features; Lupus nephritis; Systemic lupus erythematosus

Indexed keywords

HIGH DENSITY LIPOPROTEIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTHRITIS; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DISEASE SEVERITY; FAMILIAL DISEASE; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; KIDNEY BIOPSY; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RELATIVE; SIBLING; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS RASH; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 60449104634     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308097447     Document Type: Article

References (43)

1. Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies. Kidney Int 2004; 66: 920-923.
2. Nezhad ST, Sepaskhah R. Correlation of clinical and pathological findings in patients with lupus nephritis: A five-year experience in Iran. Saudi J Kidney Dis Transpl 2008; 19: 32-40.
3. Tahir H, Isenberg DA. Novel therapies in lupus nephritis. Lupus 2005; 14: 77-82.
4. Gourley IS, Cunnane G, Bresnihan B, FitzGerald O, Bell AL. A clinical and serological comparison of familial and non-familial systemic lupus erythematosus in Ireland. Lupus 1996; 5: 288-293.
5. Koskenmies S, Widen E, Kere J, Julkunen H. Familial systemic lupus erythematosus in Finland. J Rheumatol 2001; 28: 758-760.
6. Al-Mayouf SM, Al Sonbul A. Juvenile systemic lupus erythematosus in multicase families from Saudi Arabia: Comparison of clinical and laboratory variables with sporadic cases. Lupus 2006; 15: 616-618.
7. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
8. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
9. Zhu L, Yang X, Chen W, et al. Decreased expressions of the TNFalpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus. Clin Rheumatol 2007; 26: 1481-1489.
10. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-530.
11. Hu WX, Liu CB, Sun HO, et al. Clinical and immunological features of 1352 Chinese patients with lupus nephritis. Chinese Journal of Nephrology Dialysis & Transplantation 2006; 15: 401-408, 442.
12. Grande JP, Balow JE. Renal biopsy in lupus nephritis. Lupus 1998; 7: 611-617.
13. Keselman HJ, Cribbie R, Holland B. Controlling the rate of Type I error over a large set of statistical tests. Br JMath Stat Psychol 2002; 55: 27-39.
14. Grondal G, Kristjansdottir H, Gunnlaugsdottir B, et al. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. Arthritis Rheum 1999; 42: 1649-1654.
15. Block SR. A brief history of twins. Lupus 2006; 15: 61-64.
16. Kelly JA, Moser KL, Harley JB. The genetics of systemic lupus erythematosus: Putting the pieces together. Genes Immun 2002; 3 (Suppl. 1): S71-S85.
17. Harley JB, Kelly JA, Kaufman KM. Unraveling the genetics of systemic lupus erythematosus. Semin Immunopathol 2006; 28: 119-130.
18. Kaufman KM, Kelly JA, Herring BJ, et al. Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2533-2540.
19. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1714-1724.
20. Parks CG, Cooper GS, Hudson LL, et al. Association of Epstein-Barr virus with systemic lupus erythematosus: Effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 2005; 52: 1148-1159.
21. Harley JB, James JA. Epstein-Barr virus infection induces lupus autoimmunity. Bull NYU Hosp Jt Dis 2006; 64: 45-50.
22. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, et al. Grupo Latinoamericano de Estudio del Lupus Eritematoso (GLADEL). Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005; 52: 1138-1147.
23. Ghaussy NO, Sibbitt Jr W, Bankhurst AD, Qualls CR. The effect of race on disease activity in systemic lupus erythematosus. J Rheumatol 2004; 31: 915-919.
24. Liu Z-H, Cheng Z-H, Gong R-J, Liu H, Liu D, Li L-S. Sex differences in estrogen receptor gene polymorphism and its association with lupus nephritis in Chinese. Nephron 2002; 90: 174-180.
25. Rovin BH, Tang Y, Sun J, et al. Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. Kidney Int 2005; 68: 747-759.
26. Wysenbeek AJ, Guedj D, Amit M, Weinberger A. Rash in systemic lupus erythematosus: Prevalence and relation to cutaneous and noncutaneous disease manifestations. Ann Rheum Dis 1992; 51: 717-719.
27. Reilly PA, Evison G, McHugh NJ, Maddison PJ. Arthropathy of hands and feet in systemic lupus erythematosus. J Rheumatol 1990; 17: 777-784.
28. Wright S, Filippucci E, Grassi W, Grey A, Bell A. Hand arthritis in systemic lupus erythematosus: An ultrasound pictorial essay. Lupus 2006; 15: 501-506.
29. Kaarela K, Laiho K, Soini I. A 30-year result of deforming arthritis in systemic lupus erythematosus. Rheumatol Int 2007; 27: 881-882.
30. Quartuccio L, Sacco S, Franzolini N, Perin A, Ferraccioli G, De Vita S. Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus. Lupus 2006; 15: 76-79.
31. Ziakas PD, Giannouli S, Zintzaras E, Tzioufas AG, Voulgarelis M. Lupus thrombocytopenia: Clinical implications and prognostic significance. Ann Rheum Dis 2005; 64: 1366-1369.
32. Drenkard C, Villa AR. Thrombocytopenia as a prognostic factor in Hispanic patients with systemic lupus erythematosus: Comment on the article by Fernandez, et al. Arthritis Rheum 2007; 56: 2811-2812.
33. El Magadmi M, Ahmad Y, Turkie W, et al. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. J Rheumatol 2006; 33: 50-56.
34. Kamijo Y, Kaneko Y, Ichikawa T, et al. A case of nephrotic syndrome due to lupus nephritis which was controlled with low-density lipoprotein apheresis. Ther Apher 2002; 6: 459-462.
35. Luzar B, Ferluga D. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients. Wien Klin Wochenschr 2000; 112: 716-721.
36. McMahon M, Grossman J, FitzGerald J, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006; 54: 2541-2549.
37. Wang J, Hu W, Xie H, et al. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: Mycophenolate mofetil or intravenous cyclophosphamide. Lupus 2007; 16: 707-712.
38. Korbet SM, SchwartzMM, Evans J, Lewis EJ. Severe lupus nephritis: Racial differences in presentation and outcome. J Am Soc Nephrol 2007; 18: 244-254.
39. Zhu B, Chen N, Lin Y, et al. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: A meta-analysis of randomized controlled trials. Nephrol Dial Transplant 2007; 22: 1933-1942.
40. Moroni G, Pasquali S, Quaglini S, et al. Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis 1999; 34: 530-539.
41. Austin III HA, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: Importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 1995; 10: 1620-1628.
42. Dimitrijevic J, Dukanovic L, Kovacevic Z, et al. Lupus nephritis: histopathologic features, classification and histologic scoring in renal biopsy. Vojnosanit Pregl 2002; 59: 21-31.
43. Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 2005; 19: 685-708.